Skip to main content
Screener/Healthcare/Biotechnology

NKTR — Nektar Therapeutics

NASDAQ
$66.65+0.01 (+0.02%)
Mid CapHealthcare
$33.40
$109.00
$66.28
$67.65
EPS (TTM)$-10.22
P/E Ratio-10.37
Dividend Yield—
Market Cap$2.16B
Volume178K
Prev Close$66.64
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$21.8M-$36.1M$-1.78100.0%-165.4%
Q3 '25$11.8M-$35.5M$-1.8798.3%-301.3%
Q2 '25$11.2M-$41.6M$-2.95100.0%-372.2%
Q1 '25$10.5M-$50.9M$-3.62100.0%-486.4%
Q4 '24$29.2M$7.3M$0.5172.7%24.9%
Q3 '24$24.1M-$37.1M$-2.6681.6%-153.6%
Q2 '24$23.5M-$52.4M$-3.7658.5%-222.9%
Q1 '24$21.6M-$36.8M$-2.8360.6%-170.1%
Get Your Daily Market Recap